Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

HORIZON SPACE ACQUISITION I CORP USD RED WTS 12/27/2029 (Cayman Islands) · HSPWF

HSPWFOTCWarrantCurrentCIK 1946021Updated Oct 14, 2026

Company: Horizon Space Acquisition I Corp. →

HSPWF price & chart

Provider market data

Loading TradingView…

OTC:HSPWF on TradingView ↗

TradingView · Data may be delayed

About the company

Horizon Space Acquisition I Corp. is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

425 · 2026-10-13 · 0001929980-26-000543

Company description from the cited filing.

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income203,618USD · FY 2025
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

Cash— · FY 2025
Operating income-576,374USD · FY 2025
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

Diluted EPS— · FY 2025

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD1,230,570
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

21,327,906
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

68,245,763
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

70,926,038
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD———561,406
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Assets, CurrentUSD50,579
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

7,815
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

298,908
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

685,471
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD6,095,957
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

4,396,819
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

2,828,718
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

2,449,842
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD231
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

231
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

231
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

231
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Additional Paid in CapitalUSD—0
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

0
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

0
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-6,045,609
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

-4,389,235
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

-2,530,041
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

-1,744,886
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD-6,045,378
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

-4,389,004
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

-2,529,810
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

-1,744,655
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Liabilities and EquityUSD1,230,570
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

21,327,906
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

68,245,763
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

70,926,038
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD3,680,957
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

1,981,819
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

413,718
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

34,842
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Additional Financial Items
Partners' CapitalUSD—700,000
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD—2,112,351
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

——
Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——0
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Operating ActivitiesUSD-585,924
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

-975,466
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

-378,125
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD20,920,092
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

49,798,309
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

5,745,184
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—
Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD-20,306,089
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

-49,098,309
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

-5,645,184
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—
Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD35,894
Source

10-K · 2026-04-15 · 0001929980-26-000161

As of 2025-12-31

7,815
Source

10-K · 2025-03-28 · 0001929980-25-000171

As of 2024-12-31

283,281
Source

10-K · 2024-04-01 · 0001929980-24-000075

As of 2023-12-31

561,406
Source

10-K · 2023-02-13 · 0001929980-23-000010

As of 2022-12-31

Additional Financial Items
Net Income (Loss) Attributable to ParentUSD203,618
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

2,112,351
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

2,911,033
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—
Operating Costs and ExpensesUSD576,374
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

1,059,194
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

560,155
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—
Other Interest and Dividend IncomeUSD779,992
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

3,171,545
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

3,471,188
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

—

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023
Operating Income (Loss)USD-576,374
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

-1,059,194
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

-560,155
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

Net Income (Loss) Attributable to ParentUSD203,618
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

2,112,351
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

2,911,033
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

Additional Financial Items
Operating Costs and ExpensesUSD576,374
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

1,059,194
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

560,155
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

Other Cost and Expense, OperatingUSD471,374
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

661,031
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

560,155
Source

10-K · 2025-03-28 · 0001929980-25-000171

2023-01-01 to 2023-12-31

Other Interest and Dividend IncomeUSD779,992
Source

10-K · 2026-04-15 · 0001929980-26-000161

2025-01-01 to 2025-12-31

3,171,545
Source

10-K · 2025-03-28 · 0001929980-25-000171

2024-01-01 to 2024-12-31

3,471,188
Source

10-K · 2024-04-01 · 0001929980-24-000075

2023-01-01 to 2023-12-31

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

hspo_ex991.htm · 425 · 2026-10-13

EXHIBIT 99.1 Horizon Space Acquisition I Corp. Announces Definitive Business Combination Agreement with ArcheNova Biotech Corp. NEW YORK, NY, October 13, 2026 (Accesswire) - Horizon Space Acquisition I Corp. (“HSPO”) (OTC: HSPOF), a publicly traded special purpose acquisition company, and ArcheNova Biotech Corp. (“ArcheNova” or the “Company”), a clinical-stage, platform-based biopharmaceutical company, focusing on the research, development, clinical translation, scalable manufacturing and glo…

425 · 2026-10-13 · 0001929980-26-000543

Read attachment ↗
hspo_ex991.htm · 8-K · 2026-10-13

EXHIBIT 99.1 Horizon Space Acquisition I Corp. Announces Definitive Business Combination Agreement with ArcheNova Biotech Corp. NEW YORK, NY, October 13, 2026 (Accesswire) - Horizon Space Acquisition I Corp. (“HSPO”) (OTC: HSPOF), a publicly traded special purpose acquisition company, and ArcheNova Biotech Corp. (“ArcheNova” or the “Company”), a clinical-stage, platform-based biopharmaceutical company, focusing on the research, development, clinical translation, scalable manufacturing and glo…

8-K · 2026-10-13 · 0001929980-26-000542

Read attachment ↗
hspo_ex991.htm · 8-K · 2025-12-11

EX-99.1 2 hspo_ex991.htm PRESS RELEASE hspo_ex991.htm EXHIBIT 99.1 Horizon Space Acquisition I Corp. Announces Voluntary Delisting from Nasdaq Capital Market New York, December 3, 2025 -- Horizon Space Acquisition I Corp. (Nasdaq: HSPO, HSPOU, HSPOW, HSPOR) (the “Company,” “we” or “our”), a special purpose acquisition company, today notified the Nasdaq Stock Market LLC (“Nasdaq”) of the Company’s decision to voluntarily delist its ordinary shares, units, warrants, and rights from the Nasd…

8-K · 2025-12-11 · 0001929980-25-000768

Read attachment ↗
hspo_ex992.htm · 8-K · 2025-12-11

EX-99.2 3 hspo_ex992.htm PRESS RELEASE hspo_ex992.htm EXHIBIT 99.2 Horizon Space Acquisition I Corp. Announces Effective Date of Nasdaq Delisting and Commencement of OTC Trading New York, December 10, 2025 -- Horizon Space Acquisition I Corp. (Nasdaq: HSPO, HSPOU, HSPOW, HSPOR) (the “Company”), a special purpose acquisition company, today announces that its ordinary shares, units, warrants, and rights will be suspended from trading on the Nasdaq Capital Market (“Nasdaq”) prior to market o…

8-K · 2025-12-11 · 0001929980-25-000768

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.